Oxford, UK – 21 March 2025: OXB (LSE: OXB) (the "Company"), a quality and innovation-led cell and gene therapy CDMO, today announces that the Company has been recognised as a winner in the 'Cell & ...
Live webcasts and recordings of presentations, where available, will be accessible under ‘Results, Reports, Presentations & Webcasts’ in the Investor Relations section of OXB’s website at www.oxb.com.
Progression to full ownership aligns with global strategy and supports long-term growth in the viral vector manufacturing market Oxford, UK - 23 June 2025: OXB (LSE: OXB) ("the Company”), a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback